DHR vs HCA: fair value comparison
Danaher Corporation and HCA Healthcare, Inc. · Updated 2026-09-12
DHR currently screens as undervalued while HCA screens as fairly valued. Within Healthcare, DHR currently sits closer to the top of our discount ranking. DHR carries the stronger quality grade.
| DHR | HCA | |
|---|---|---|
| Verdict | Undervalued | Fairly valued |
| Last price | $200.14 | $426.94 |
| 12-month range | $175.15–$230.40 | $370.96–$532.92 |
| Sector rank | #58 of 113 Healthcare | #62 of 113 Healthcare |
| Quality grade | B | D |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: DHR fair value analysis · HCA fair value analysis